<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39370947</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1475-2727</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Public health nutrition</Title><ISOAbbreviation>Public Health Nutr</ISOAbbreviation></Journal><ArticleTitle>Associations between pre-infection serum vitamin D concentrations and Omicron COVID-19 incidence, severity and reoccurrence in elderly individuals.</ArticleTitle><Pagination><StartPage>e197</StartPage><MedlinePgn>e197</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e197</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/S1368980024001873</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Previous studies suggest a link between vitamin D status and COVID-19 susceptibility in hospitalised patients. This study aimed to investigate whether vitamin D concentrations in elderly individuals were associated with their susceptibility to Omicron COVID-19 incidence, the severity of the disease and the likelihood of reoccurrence during the era of the post-'zero-COVID-19' policies in China.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">In this retrospective study, participants were categorised into three groups based on their 25(OH)D concentrations: deficiency (&lt; 20 ng/ml), insufficiency (20 to &lt; 30 ng/ml) and sufficiency (≥ 30 ng/ml). The demographic and clinical characteristics, comorbidities and the incidence rate, reoccurrence rate and severity of Omicron COVID-19 were retrospectively recorded and analysed by using hospital information system data and an online questionnaire survey.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">China.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">222 participants aged 60 years or older from a health management centre.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our findings revealed significant differences in the incidence (<i>P</i> = 0·03) and recurrent rate (<i>P</i> = 0·02) of Omicron COVID-19 among the three groups. Participants with lower 25(OH)D concentrations (&lt; 20 ng/ml) exhibited higher rates of initial incidence and reoccurrence and a greater percentage of severe and critical cases. Conversely, individuals with 25(OH)D concentrations ≥ 30 ng/ml had a higher percentage of mild cases (<i>P</i> = 0·003). Binary and ordinal logistic regression models indicated that vitamin D supplementation was not a significant risk factor for COVID-19 outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In the elderly population, pre-infection vitamin D deficiency was associated with increased susceptibility to incidence, severity of illness and reoccurrence rates of Omicron COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jiangjie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bone Metabolism and Development Research Center, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang Province317000, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedics, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Fangying</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Bone Metabolism and Development Research Center, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang Province317000, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedics, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hongfang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Health Management Center, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yijun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Bone Metabolism and Development Research Center, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang Province317000, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedics, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Anpeng</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Linhai Second People's Hospital of Taizhou, Linhai, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Tao-Hsin</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Enze Medical Center, Taizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Dun</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2094-4987</Identifier><AffiliationInfo><Affiliation>Bone Metabolism and Development Research Center, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang Province317000, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedics, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Public Health Nutr</MedlineTA><NlmUniqueID>9808463</NlmUniqueID><ISSNLinking>1368-9800</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="Y">Vitamin D</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014808" MajorTopicYN="Y">Vitamin D Deficiency</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Incidence and reoccurrence rate</Keyword><Keyword MajorTopicYN="N">Omicron COVID-19</Keyword><Keyword MajorTopicYN="N">Severity of illness</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword><Keyword MajorTopicYN="N">Vitamin D deficiency</Keyword></KeywordList><CoiStatement>There are no conflicts of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>4</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39370947</ArticleId><ArticleId IdType="pmc">PMC11505208</ArticleId><ArticleId IdType="doi">10.1017/S1368980024001873</ArticleId><ArticleId IdType="pii">S1368980024001873</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Holick MF (2017) The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18, 153–165.</Citation><ArticleIdList><ArticleId IdType="pubmed">28516265</ArticleId></ArticleIdList></Reference><Reference><Citation>Lips P (2007) Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 103, 620–625.</Citation><ArticleIdList><ArticleId IdType="pubmed">17287117</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui A, Xiao P, Ma Y et al. (2022) Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001–2018. Front Nutr 9, 965376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9573946</ArticleId><ArticleId IdType="pubmed">36263304</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark A &amp; Mach N (2016) Role of vitamin D in the hygiene hypothesis: the interplay between vitamin D, vitamin D receptors, gut microbiota, and immune response. Front Immunol 7, 627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5179549</ArticleId><ArticleId IdType="pubmed">28066436</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan M &amp; Priyanka Choudhary OP (2022) Immunomodulatory and therapeutic implications of vitamin D in the management of COVID-19. Hum Vaccin Immunother 18, 2025734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8993102</ArticleId><ArticleId IdType="pubmed">35072581</ArticleId></ArticleIdList></Reference><Reference><Citation>AlSafar H, Grant WB, Hijazi R et al. (2021) COVID-19 disease severity and death in relation to vitamin D status among SARS-CoV-2-positive UAE residents. Nutrients 13, 1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8159141</ArticleId><ArticleId IdType="pubmed">34069412</ArticleId></ArticleIdList></Reference><Reference><Citation>Basińska-Lewandowska M, Lewandowski K, Horzelski W et al. (2023) Frequency of COVID-19 infection as a function of vitamin D levels. Nutrients 15, 1581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10097275</ArticleId><ArticleId IdType="pubmed">37049423</ArticleId></ArticleIdList></Reference><Reference><Citation>Karonova TL, Andreeva AT, Golovatuk KA et al. (2021) Low 25(OH)D level is associated with severe course and poor prognosis in COVID-19. Nutrients 13, 3021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8468115</ArticleId><ArticleId IdType="pubmed">34578898</ArticleId></ArticleIdList></Reference><Reference><Citation>Seal KH, Bertenthal D, Carey E et al. (2022) Association of vitamin D status and COVID-19-related hospitalization and mortality. J Gen Intern Med 37, 853–861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8723909</ArticleId><ArticleId IdType="pubmed">34981368</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen NM, Junker TG, Boelt SG et al. (2022) Vitamin D status and severity of COVID-19. Sci Rep 12, 19823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9672358</ArticleId><ArticleId IdType="pubmed">36396686</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman HW, Niles JK, Kroll MH et al. (2020) SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One 15, e0239252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7498100</ArticleId><ArticleId IdType="pubmed">32941512</ArticleId></ArticleIdList></Reference><Reference><Citation>Basaran N, Adas M, Gokden Y et al. (2021) The relationship between vitamin D and the severity of COVID-19. Bratisl Lek Listy 122, 200–205.</Citation><ArticleIdList><ArticleId IdType="pubmed">33618529</ArticleId></ArticleIdList></Reference><Reference><Citation>Baktash V, Hosack T, Patel N et al. (2021) Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J 97, 442–447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7456620</ArticleId><ArticleId IdType="pubmed">32855214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari D, Locatelli M, Faraldi M et al. (2021) Changes in 25-(OH) vitamin D levels during the SARS-CoV-2 outbreak: lockdown-related effects and first-to-second wave difference-an observational study from Northern Italy. Biology (Basel) 10, 237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8003430</ArticleId><ArticleId IdType="pubmed">33808612</ArticleId></ArticleIdList></Reference><Reference><Citation>AlKhafaji D, Al Argan R, Albaker W et al. (2022) The impact of vitamin D level on the severity and outcome of hospitalized patients with COVID-19 disease. Int J Gen Med 15, 343–352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8752578</ArticleId><ArticleId IdType="pubmed">35027842</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jarallah M, Rajan R, Dashti R et al. (2021) In-hospital mortality in SARS-CoV-2 stratified by serum 25-hydroxy-vitamin D levels: a retrospective study. J Med Virol 93, 5880–5885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242815</ArticleId><ArticleId IdType="pubmed">34101207</ArticleId></ArticleIdList></Reference><Reference><Citation>De Smet D, De Smet K, Herroelen P et al. (2021) Serum 25(OH)D level on hospital admission associated with COVID-19 stage and mortality. Am J Clin Pathol 155, 381–388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717135</ArticleId><ArticleId IdType="pubmed">33236114</ArticleId></ArticleIdList></Reference><Reference><Citation>Campi I, Gennari L, Merlotti D et al. (2021) Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy. BMC Infect Dis 21, 566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8200788</ArticleId><ArticleId IdType="pubmed">34126960</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagiotou G, Tee SA, Ihsan Y et al. (2020) Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol (Oxf) 93, 508–511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361912</ArticleId><ArticleId IdType="pubmed">32621392</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves FF, Pott-Junior H, de Sousa Santos S et al. (2022) Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19. Clin Nutr ESPEN 50, 322–325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9195455</ArticleId><ArticleId IdType="pubmed">35871942</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanegas-Cedillo PE, Bello-Chavolla OY, Ramirez-Pedraza N et al. (2022) Serum vitamin D levels are associated with increased COVID-19 severity and mortality independent of whole-body and visceral adiposity. Front Nutr 9, 813485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8825804</ArticleId><ArticleId IdType="pubmed">35155539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecina JL, Merry SP, Park JG et al. (2021) Vitamin D status and severe COVID-19 disease outcomes in hospitalized patients. J Prim Care Community Health 12, 21501327211041206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8404616</ArticleId><ArticleId IdType="pubmed">34452582</ArticleId></ArticleIdList></Reference><Reference><Citation>Radujkovic A, Hippchen T, Tiwari-Heckler S et al. (2020) Vitamin D deficiency and outcome of COVID-19 patients. Nutrients 12, 2757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7551780</ArticleId><ArticleId IdType="pubmed">32927735</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulli A, Gotelli E, Casabella A et al. (2021) Vitamin D and lung outcomes in elderly COVID-19 patients. Nutrients 13, 717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7996150</ArticleId><ArticleId IdType="pubmed">33668240</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolders J, van den Ouweland J, Geven C et al. (2021) Letter to the editor: vitamin D deficiency in COVID-19: mixing up cause and consequence. Metabolism 115, 154434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7671645</ArticleId><ArticleId IdType="pubmed">33217408</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Pell JP &amp; Sattar N (2021) Vitamin D and COVID-19 infection and mortality in UK Biobank. Eur J Nutr 60, 545–548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449523</ArticleId><ArticleId IdType="pubmed">32851419</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler-Laporte G, Nakanishi T, Mooser V et al. (2021) Vitamin D and COVID-19 susceptibility and severity in the COVID-19 host genetics initiative: a Mendelian randomization study. PLoS Med 18, e1003605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168855</ArticleId><ArticleId IdType="pubmed">34061844</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Sun J, Wang X et al. (2021) Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis. Int J Infect Dis 104, 58–64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833186</ArticleId><ArticleId IdType="pubmed">33401034</ArticleId></ArticleIdList></Reference><Reference><Citation>Dissanayake HA, de Silva NL, Sumanatilleke M et al. (2022) Prognostic and therapeutic role of vitamin D in COVID-19: systematic review and meta-analysis. J Clin Endocrinol Metab 107, 1484–1502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689831</ArticleId><ArticleId IdType="pubmed">34894254</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Gao Z &amp; Wang S (2023) China’s COVID-19 reopening measures-warriors and weapons. Lancet 401, 643–644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9949835</ArticleId><ArticleId IdType="pubmed">36841613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Zhou W, Tang S et al. (2023) Prediction of the next major outbreak of COVID-19 in Mainland China and a vaccination strategy for it. R Soc Open Sci 10, 230655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10465198</ArticleId><ArticleId IdType="pubmed">37650063</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC (2023) National Epidemic Situation of COVID-19 Disease (2023–02–01). https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202302/t20230201_263576.html (accessed 14 September 2023).</Citation></Reference><Reference><Citation>El-Khoury JM, Reineks EZ &amp; Wang S (2011) Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin Biochem 44, 66–76.</Citation><ArticleIdList><ArticleId IdType="pubmed">20493831</ArticleId></ArticleIdList></Reference><Reference><Citation>Volmer DA, Mendes LR &amp; Stokes CS (2015) Analysis of vitamin D metabolic markers by mass spectrometry: current techniques, limitations of the ‘gold standard’ method, and anticipated future directions. Mass Spectrom Rev 34, 2–23.</Citation><ArticleIdList><ArticleId IdType="pubmed">24318020</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandridou A, Schorr P, Stokes CS et al. (2023) Analysis of vitamin D metabolic markers by mass spectrometry: recent progress regarding the ‘gold standard’ method and integration into clinical practice. Mass Spectrom Rev 42, 1647–1687.</Citation><ArticleIdList><ArticleId IdType="pubmed">34967037</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF (2007) Vitamin D deficiency. N Engl J Med 357, 266–281.</Citation><ArticleIdList><ArticleId IdType="pubmed">17634462</ArticleId></ArticleIdList></Reference><Reference><Citation>General Office of National Health Commission &amp; The General Office of National Administration of Traditional Chinese Medicine (2022) Diagnosis and treatment protocol for COVID-19 patients (tentative 9th version). Infect Dis Immun 2, 135–144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9295936</ArticleId><ArticleId IdType="pubmed">37520110</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Mackay DF, Ho F et al. (2020) Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr 14, 561–565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204679</ArticleId><ArticleId IdType="pubmed">32413819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, Zhou T, Heianza Y et al. (2021) Habitual use of vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infection: a prospective study in UK Biobank. Am J Clin Nutr 113, 1275–1281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929381</ArticleId><ArticleId IdType="pubmed">33515005</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana R, Kant R, Huirem RS et al. (2022) Omicron variant: current insights and future directions. Microbiol Res 265, 127204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9482093</ArticleId><ArticleId IdType="pubmed">36152612</ArticleId></ArticleIdList></Reference><Reference><Citation>Villasis-Keever MA, Lopez-Alarcon MG, Miranda-Novales G et al. (2022) Efficacy and safety of vitamin D Supplementation To Prevent COVID-19 in frontline healthcare workers. A randomized clinical trial. Arch Med Res 53, 423–430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013626</ArticleId><ArticleId IdType="pubmed">35487792</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe DA, Holt H, Greenig M et al. (2022) Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ 378, e071230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9449358</ArticleId><ArticleId IdType="pubmed">36215226</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolsk HM, Harshfield BJ, Laranjo N et al. (2017) Vitamin D supplementation in pregnancy, prenatal 25(OH)D levels, race, and subsequent asthma or recurrent wheeze in offspring: secondary analyses from the Vitamin D Antenatal Asthma Reduction Trial. J Allergy Clin Immunol 140, 1423–1429 e1425.</Citation><ArticleIdList><ArticleId IdType="pubmed">28285844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzakhani H, Litonjua AA, McElrath TF et al. (2016) Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest 126, 4702–4715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127689</ArticleId><ArticleId IdType="pubmed">27841759</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>